Compare Novo Nordisk A/S (NVO) vs Paycom Software Inc (PAYC) Price & Performance

Novo Nordisk A/STrade

Paycom Software IncTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Paycom Software Inc — how do they compare? Novo Nordisk A/S trades at $45.86 (market cap $207.31B), while Paycom Software Inc trades at $211 (market cap $9.62B). The key difference: Novo Nordisk A/S is far larger — about 21.5× Paycom Software Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.76%). Which is the better fit depends on your goals.

	NVO	PAYC
Market Cap	$207.31B	$9.62B
Sector	Health	Technology
52-Week High	$63.98	$233.89
52-Week Low	$35.29	$113.59
Enterprise Value	$222.02B	$10.41B
Dividend Yield	3.76%	0.7%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novo Nordisk A/S

No Aura AI signal available yet.

Paycom Software Inc

Paycom Software (PAYC) trades at $214.94, down 0.48% on the day, with a bullish technical signal supported by moving averages. The stock exhibits strong fundamentals, including a 22.78% net income margin and consistent earnings beats, most recently with Q2 2026 EPS of $2.78 versus $2.38 expected. Recent news highlights AI-driven demand and raised 2026 guidance, fueling positive sentiment.

Outlook remains favorable due to robust profitability and growth initiatives, though risks include high valuation multiples and competitive pressures. Analyst consensus is mixed with a $219.22 price target, suggesting modest upside potential from current levels amid balanced buy/hold ratings.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVO

Novo Nordisk downgraded to Sell on weak growth and operational issues despite strong semaglutide sales.Seeking Alpha · 4 days agoBearish View details →

PAYC

Paycom posts 10% revenue growth in Q2, shares jump 23% after strong earnings and raised guidanceSeeking Alpha · 1 day agoBullish Global X Cloud Computing ETF (CLOU) rated buy for strong growth beyond AI and resilient revenue streamsSeeking Alpha · 2 days agoBullish View details →

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About Paycom Software Inc

Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.